Spotlight: Scaling the in vivo moment: Why delivery, data and execution now decide how far and how fast programmes progress

Biology isn’t the only limiter anymore: As in vivo programmes advance, why delivery consistency, biodistribution insight and execution infrastructure are becoming the real differentiators.

Where momentum quietly stalls: Common execution gaps seen across in vivo programmes spanning translation, monitoring, comparability and scalability that slow progression even when data looks promising.

Designing for momentum, not heroics: How thinking earlier about delivery strategy, data capture and operational readiness can materially improve pace and confidence without increasing risk.

What ‘ready to scale’ now means for in vivo: The enabling capabilities programmes increasingly need in place before they reach inflection points in the clinic.